Aim: To compare body composition in children with Prader-Willi syndrome (PWS) not naïve to growth hormone (GH) with obese and lean controls. Methods: Participants included 12 children with PWS, 12 children with obesity (body fat percentage >95th percentile for age and sex) and 12 lean children (body fat percentage <85th percentile for age and sex) matched by age and height. Fat mass, lean mass, bone mineral content (BMC), bone mineral density (BMD) and BMD z-score for total body, hips and lumbar spine were obtained through dual X-ray absorptiometry. Results: PWS had higher fat percentage in the legs (p = 0.04) but similar leg fat mass (p = 1.00) compared to obese. PWS exhibited lower lean mass in the body (p = 0.04) and legs (p = 0.02) than obese, but similar to lean (p = 1.00 and p = 0.89, respectively). PWS had lower hip BMC (p < 0.01), BMD (p < 0.01) and BMD z-score (p < 0.01) compared to obese but similar to lean. No other differences were found between PWS and obese (p > 0.05 for all). Conclusions: Children with PWS not naïve to GH present differences in fat and lean mass distribution compared to obese controls. BMC and BMD appear unaffected by PWS, except at the hips.

1.
Rogol AD: Sex steroids, growth hormone, leptin and the pubertal growth spurt. Endocr Dev 2010;17:77-85.
2.
Scerpella TA, Dowthwaite JN, Rosenbaum PF: Sustained skeletal benefit from childhood mechanical loading. Osteoporos Int 2010;22:2205-2210.
3.
Afghani A, Goran MI: Racial differences in the association of subcutaneous and visceral fat on bone mineral content in prepubertal children. Calcif Tissue Int 2006;79:383-388.
4.
Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD: Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94:3387-3393.
5.
Cassidy SB, Driscoll DJ: Prader-Willi syndrome. Eur J Hum Genet 2009;17:3-13.
6.
Theodoro MF, Talebizadeh Z, Butler MG: Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obesity 2006;14:1685-1690.
7.
Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID: Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet 2001;103:216-222.
8.
Vestergaard P, Kristensen K, Bruun JM, Ostergaard JR, Heickendorff L, Mosekilde L, et al: Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index - a cross-sectional study. J Pediatr 2004;144:614-619.
9.
Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T: Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 2002;44:248-255.
10.
Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G: Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr 1997;65:1369-1374.
11.
van Mil EG, Westerterp KR, Gerver WJ, Van Marken Lichtenbelt WD, Kester AD, Saris WH: Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: relationship to physical activity and growth hormone function. J Pediatr 2001;139:708-714.
12.
Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB: Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2010;95:1131-1136.
13.
de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, et al: Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2009;94:4205-4215.
14.
Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, et al: Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr 2010;75:123-130.
15.
de Lind van Wijngaarden RF, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, et al: Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial. J Clin Endocrinol Metab 2009;94:3763-3771.
16.
Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH: Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 2003;88:2206-2212.
17.
McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM: Body fat reference curves for children. Int J Obes 2006;30:598-602.
18.
Bachrach LK, Hastie T, Wang MC, Narasimhan B, Marcus R: Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999;84:4702-4712.
19.
Petersen AC, Crockett L, Richards M, Boxer A: A self-report measure of pubertal status: reliability, validity, and initial norms. J Youth Adolesc 1988;17:117-133.
20.
Novotny R, Going S, Teegarden D, Van Loan M, McCabe L, Daida YG, Boushey CJ: Hispanic and Asian pubertal girls have higher android/gynoid fat ratio than Whites. Obesity 2007;15:1565-1570.
21.
Brismar TB, Lindgren AC, Ringertz H, Rosenborg M, Ritzen ME: Total body bone mineral measurements in children with Prader-Willi syndrome: the influence of the skull's bone mineral content per area (BMA) and of height. Pediatr Radiol 1998;28:38-42.
22.
van den Berg-Emons R, Festen D, Hokken-Koelega A, Bussmann J, Stam H: Everyday physical activity and adiposity in Prader-Willi syndrome. J Pediatr Endocrinol Metab 2008;21:1041-1048.
23.
Baxter-Jones AD, Eisenmann JC, Mirwald RL, Faulkner RA, Bailey DA: The influence of physical activity on lean mass accrual during adolescence: a longitudinal analysis. J Appl Physiol 2008;105:734-741.
24.
Hind K, Burrows M: Weight-bearing exercise and bone mineral accrual in children and adolescents: a review of controlled trials. Bone 2007;40:14-27.
25.
Larson CM, Henderson RC: Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 2000;20:71-74.
26.
Wey HE, Binkley TL, Beare TM, Wey CL, Specker BL: Cross-sectional versus longitudinal associations of lean and fat mass with pQCT bone outcomes in children. J Clin Endocrinol Metab 2011;96:106-114.
27.
Hui SL, Slemenda CW, Johnston CC Jr: The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1990;1:30-34.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.